![](/img/cover-not-exists.png)
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., Soubrie, P.Volume:
99
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.092012099
Date:
April, 2002
File:
PDF, 345 KB
english, 2002